NHS patients may receive new medicines faster under a series of pilots announced by the Department of Health and Social Care on 2 July 2026. The pilots, developed by a joint government, industry and NHS taskforce, will test new approaches to pricing, access and adoption of innovative treatments beginning in September. One pilot focuses on delivering already‑tested therapies for rare conditions more quickly. The announcement follows a change to NICE’s cost‑effectiveness threshold in April that has already added nine new medicines to NHS lists in England and Wales. The pilots aim to allow faster, fairer access while ensuring value for taxpayers, and could add up to five additional medicines per year. They are part of the UK‑US pharmaceutical agreement to double innovation spending to 0.6 % of GDP over the next decade.
© Crown copyright, 2024, GOV.UK.
Summary adapted from content licensed under the Open Government Licence v3.0.
For details, see https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/.
Original source: https://www.gov.uk/
Made by AI. If you spot anything of concern write us at contact@cybach.com. We’ll promptly correct irregularities.